Mycin is an early AI program developed in the 1970s by Edward Shortliffe and his team at Stanford University. It was designed to help diagnose and treat bacterial infections, particularly meningitis, by using a rule-based system that analyzed patient symptoms and medical history to suggest appropriate antibiotic treatments. Mycin was one of the first successful applications of AI in medicine and paved the way for further developments in the field.
Mycin's main feature is its rule-based system, which uses backward chaining to analyze patient symptoms and medical history and suggest appropriate antibiotic treatments, with dosages adjusted for the patient's body weight. The program's knowledge base of rules, developed by expert physicians in infectious disease, is organized into a hierarchical structure that lets Mycin reason about aspects of a patient's condition such as age, sex, and prior medical history. Mycin was also applied to diagnosing blood clotting diseases, and it can ask follow-up questions to clarify ambiguous information or gather more details about a patient's symptoms.
Mycin operated using a base of several hundred rules (commonly cited as 450–600, depending on the version) and various yes/no questions. It was a stand-alone system that required a user to enter all relevant information about a patient. The system would then attempt to diagnose patients based on reported symptoms and medical test results. If necessary, Mycin could request further information concerning the patient, as well as suggest additional laboratory tests, to arrive at a probable diagnosis. After diagnosing, it would recommend a course of treatment. If requested, Mycin would explain the reasoning that led to its diagnosis and recommendation.
Mycin was advanced for its time and had a competence level comparable to human specialists in diagnosing blood infections. The thought processes that it used were similar to human thought. It was the first system of its kind invented for medical usage. Furthermore, Mycin's greatest influence was its demonstration of the power of its representation and rule-based systems in many non-medical domains. Rule-based systems in many non-medical domains were developed in the years that followed Mycin's introduction.
Despite its advanced capabilities, Mycin was never actually used in practice. This wasn't because of any weakness in its performance. Some observers raised ethical and legal issues related to the use of computers in medicine, regarding the responsibility of the physicians in case the system gave a wrong diagnosis. However, the greatest problem, and the reason that Mycin was not used in routine practice, was the state of system integration tools, especially when Mycin was made. Mycin was a stand-alone system that asked the user to type in answers to questions about a patient, which was not practical for routine use. Rule-based systems like Mycin also proved brittle, hard to maintain, and too costly.
More terms
Glossary term
Glossary term
Collaborate with your team on reliable Generative AI features.
Want expert guidance? Book a 1:1 onboarding session from your dashboard.